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It has been documented in in vitro studies that zinc oxide nanoparticles (ZnO NPs) are capable of inducing
oxidative stress, which plays a crucial role in ZnO NP-mediated apoptosis. However, the underlying molecular
mechanism of apoptosis in neurocytes induced by ZnO NP exposure was not fully elucidated. In this study, we
investigated the potential mechanisms of apoptosis provoked by ZnO NPs in cultured primary astrocytes by
exploring the molecular signaling pathways triggered after ZnO NP exposure. ZnO NP exposure was found to
reduce cell viability in MTT assays, increase lactate dehydrogenase (LDH) release, stimulate intracellular reactive
oxygen species (ROS) generation, and elicit caspase-3 activation in a dose- and time-dependent manner. Apoptosis
occurred after ZnO NP exposure as evidenced by nuclear condensation and poly(ADP-ribose) polymerase-1 (PARP)
cleavage. A decrease in mitochondrial membrane potential (MMP) with a concomitant increase in the expression
of Bax/Bcl-2 ratio suggested that the mitochondria also mediated the pathway involved in ZnO NP-induced apoptosis.
In addition, exposure of the cultured cells to ZnO NPs led to phosphorylation of c-Jun N-terminal kinase (JNK),
extracellular signal-related kinase (ERK), and p38 mitogen-activated protein kinase (p38 MAPK). Moreover, JNK inhibitor
(SP600125) significantly reduced ZnO NP-induced cleaved PARP and cleaved caspase-3 expression, but not ERK
inhibitor (U0126) or p38 MAPK inhibitor (SB203580), indicating that JNK signaling pathway is involved in ZnO
NP-induced apoptosis in primary astrocytes.
Keywords: Zinc oxide nanoparticles; Astrocytes; Oxidative stress; Apoptosis; JNKBackground
In the last decades, zinc oxide nanoparticles (ZnO NPs), as
a new type of high-functional nanoparticles, have been
widely used in cosmetics, food additives, biosensors, and
pharmaceuticals [1-4]. With the increased application of
ZnO NPs, the concerns about their potential hazards and
safety have also been increased. It has been known that
with decreasing particle size, nanoparticles can easily accu-
mulate and migrate deeply in the body. Recently, some
studies have demonstrated that inhaled nanoparticles were
translocated to the central nervous system through the ol-
factory neuronal pathway [4-6], resulting in inflammatory
changes and brain edema formation [7]. ZnO NPs have
been considered as one of the most toxic nanoparticles [8].
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in any medium, provided the original work is pthat ZnO NPs are toxic to mammalian cells [9-12]. A series
of cytotoxic effects exposed to ZnO NPs are observed, such
as oxidative damage and cell death [10,12,13].
Oxidative stress has been recognized as an important
mechanism underlying the toxic effects of metal oxide
NPs, which has been extensively studied in vitro and
in vivo [14-16]. Oxidative stress is definitely caused by
an imbalance between production of various reactive
oxygen species (ROS) and antioxidant defense [17], and
ROS has been identified as signaling molecules in vari-
ous pathways regulating both cell survival and cell death
[18,19]. Excessive levels of ROS, mainly radical form,
can cause severe damage to DNA, RNA, and proteins
[20]. Recently, a number of previous studies have demon-
strated that oxidative stress is involved in ZnO NP cyto-
toxicity [21-24]. ROS can potently inhibit neurogenesis
[25]. It was confirmed that oxidative damage can also
affect the glial cells, which are associated with neuronaln Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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stress and glia-derived ROS are critical for apoptosis-
induced selective loss of neurons [27,28]. Exposure to
ZnO NPs lead to cytotoxicity in neuro-2A, neural stem
cell, and SHSY5Y cells [9,12,29]. However, the triggering
mechanisms of ZnO NP-mediated oxidative stress led
to apoptotic process in cultured primary neurocytes are
poorly understood.
Several signaling transduction pathways, including c-Jun
N-terminal kinase (JNK), extracellular signal-related kin-
ase (ERK), and p38 mitogen-activated protein kinase (p38
MAPK), have been implicated in apoptosis [30,31]. JNK is
activated by oxidative stress, which modulates cellular
functions in the neurons [32]. It has been demonstrated
that JNK is involved in the mitochondrial apoptotic path-
way in some stress responses [33]. Persistent activation
of ERK contributes to oxidative neuronal injury in both
neurons and astrocytes [34]. Prolonged activation of
ERK triggers glutamate-induced apoptosis of astro-
cytes [35]. p38 MAPK phosphorylation has also been
shown in cultured astrocytes in response to oxidant
signaling [36]. However, the molecular mechanisms
underlying ZnO NP-related induction of apoptosis
have not been fully elucidated.
The purpose of the present study is to delineate the
oxidative stress-mediated mechanism by ZnO NPs,




ZnO NPs were obtained from HT Nano Company (Nanjing,
China). Dulbecco's modified Eagle's medium/nutrient
mixture F12 (DMEM/F12) was purchased from Invitrogen
(Carlsbad, CA, USA). Fetal bovine serum (FBS) was obtained
from PAA (Pasching, Austria). 3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT), N-acetylcysteine
(NAC), and 2′,7′-dichlorodihydrofluorescein diacetate
(H2DCFDA) were obtained from Sigma-Aldrich (St.
Louis, MO, USA). SP600125 and SB203580 were ob-
tained from Beyotime (Shanghai, China). U0126 was
obtained from Promega (Madison, WI, USA). Bicincho-
ninic acid (BCA) protein assay kit was obtained from
Pierce (Rockford, IL, USA). Annexin V-FITC apoptosis
kit was purchased from Abcam (Mountain View, CA,
USA). Bcl-2, Bax, JNK, ERK1/2, p38 MAPK, phosphor-
JNK, phosphor-ERK1/2, phosphor-p38, and caspase-3
antibodies were purchased from Bioworld (St. Louis
Park, MN, USA); poly(ADP-ribose) polymerase-1 (PARP)
was purchased from Cell Signaling Technology (Boston,
MA, USA); β-actin and secondary antibodies (goat
anti-mouse or anti-rabbit IgG-conjugated horseradish
peroxidase (HRP)) were purchased from Beyotime
(Shanghai, China).Characterization of ZnO NPs
The shape of ZnO NPs was visualized under a transmis-
sion electron microscopy (TEM, CM120, Philips,
Amsterdam, the Netherlands) at an accelerating voltage
of 100 kV and at least four fields of view.
The average hydrodynamic size of ZnO NPs in water
and cell culture medium was determined by dynamic
light scattering (DLS; Nano-Zetasizer, 1000 HS, Malvern
Instrument Ltd., Worcestershire, UK). Briefly, ZnO NPs
was suspended in Milli-Q water and cell culture medium,
respectively. The suspensions were sonicated for 30 s
at 40 W by ultrasonic processor (VCX130, Sonics &
Materials Inc, Newtown, CT, USA).
The surface area of ZnO NPs was determined by mul-
tipoint nitrogen adsorption using a Brunauer-Emmett-
Teller (BET; ASAP2010, USA).
Primary cell culture and ZnO NPs treatment
The procedure was modified from preparation of separ-
ate astroglial and oligodendroglial cell cultures from rat
cerebral tissue as described in the methods of Shahar
[37]. In brief, neonatal Sprague-Dawley rats (1-day-old)
were obtained from Beijing University Medical Labora-
tory Animal Center. The brain was removed and trans-
ferred to a 60-mm Petri dish and then rinsed with a
squirt of modified DMEM/F12 culture medium contain-
ing 2 mM of glutamine. The cerebral cortex was gently
removed from the individual cortical lobes and then im-
mediately placed into a fresh 60-mm Petri dish. The cor-
tices were dissociated into cell suspension. The cell
suspensions were plated in 25-cm2 tissue culture flasks
at a concentration of 2 × 105 cells/ml. The cells were cul-
tured in DMEM/F12 culture medium in 5% CO2 atmos-
phere at 37°C. Twenty-four hours after the initial plating,
the medium was changed to preserve the adhering astro-
cytes and to remove the neurons and oligodendrocytes.
The medium was changed once every 3 days. The astro-
cytes were maintained in DMEM/F12 containing 10% fetal
bovine serum, 100 IU/ml penicillin, and 10 μg/ml strepto-
mycin. The purity of astrocytes was assessed by GFAP-
immunostaining according to the Weinstein method [38].
In these conditions, we can assume that over 95% of the
cells were astrocytes. All cell exposure experiments were
performed at 80% to 90% of cell confluence with viability
of ≥90% as determined by trypan blue staining.
The astrocytes (2 × 105 cells/ml) were first cultured in
96-well plates (Costar, Cambridge, MA, USA) for 24 h
prior to treatment. Then the culture medium was re-
placed with serum-free medium, and the cells were ex-
posed to freshly dispersed ZnO NPs preparations at the
final concentrations of 4, 8, or 12 μg/ml for 6, 12, or
24 h, respectively. Under the same conditions, astrocytes
were pretreated for 1 h with 5 mM of NAC before a 6-h
co-exposure with or without ZnO NPs (12 μg/ml). For
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treated with inhibitor of JNK, ERK, and p38 MAPK
pathway (10 μM of SP600125, U0126, and SB203580, re-
spectively) and then treated with ZnO NPs for the indi-
cated duration and concentration.
Cell viability assay
The effect of ZnO NPs on the viability of astrocytes was
measured using the MTT assay according to the method
of Deng et al. [39]. After exposure to 4, 8, or 12 μg/ml of
ZnO NPs for 6, 12, or 24 h, 10 μl of MTT (5 mg/ml in
phosphate buffer solution (PBS)) diluted by 90 μl medium
was added to each well and incubated for 1 h at 37°C. The
cells were then treated with 100 μl of dimethyl sulfoxide
(DMSO). The absorbance was quantified at 570 nm using
a microplate spectrophotometer (Thermo MK3, Thermo-
Scientific Instruments, Cambridge, MA, USA). The result
was reported as viability with respect to untreated cells.
SEM and TEM observation
Astrocytes were grown on coverslips to a semiconfluent
state and then treated with ZnO NPs at the final con-
centration of 12 μg/ml. After exposure to 12 μg/ml of
ZnO NPs for 6 h, the cells were fixed with 2% glutaral-
dehyde in 0.1 M cacodylate buffer (pH 7.3), added with
2% sucrose at room temperature for 2 h, then dehy-
drated using graded ethanol concentrations, critical
point-dried in CO2, and gold-coated by sputtering. The
samples were then examined by scanning electron mi-
croscopy (SEM; JSM-6700 F, JEOL Ltd, Tokyo, Japan).
Astrocytes were grown in 50.4-cm2 culture dishes and
then treated with ZnO NPs at the final concentration of
12 μg/ml for 6 h. The cells were fixed with 2% glutaral-
dehyde in 0.1 M cacodylate buffered (pH 7.4) at 4°C
overnight and then postfixed with 1% OsO4 in 0.1 M so-
dium cacodylate buffer (pH 7.4) at 4°C for 2 h. After de-
hydration with ascending concentrations of ethanol (50%
to 100%), the samples were embedded at 60°C for 2 days.
Ultrathin sections (80 nm) were stained with uranyl
acetate and lead citrate. The sections were examined by
transmission electron microscopy (CM120, Philips,
Netherlands) at 80 kV.
LDH assay
The level of lactate dehydrogenase (LDH) released
from astrocytes was measured to evaluate the cytotox-
icity of ZnO NPs. Briefly, astrocytes were treated with
4, 8, or 12 μg/ml of ZnO NPs for 6, 12, or 24 h, respect-
ively. The cell-free supernatant was separated by centri-
fuge (2,000 rpm, 5 min). The culture supernatants were
transferred to clean flat-bottom plate for enzymatic
analysis. The activity of LDH in the supernatants was
determined using LDH detection kit (Nanjing Jiancheng
Bioengineering Institute, Nanjing, China) according to themanufacturer's instructions. All samples were assayed in
duplicates for LDH content by a microplate spectropho-
tometer (Thermo MK3, MA, USA).
ROS assay
The intracellular levels of ROS were determined by meas-
uring the oxidative conversion of DCFH-DA to fluores-
cent compound dichlorofluorescin (DCFH) [40]. Briefly,
astrocytes were placed in 24-well for 12 h, then treated
with 4, 8, or 12 μg/ml of ZnO NPs for 6, 12, or 24 h, incu-
bated with DCF diacetate in culture medium for 15 min,
and washed with cold phosphate buffer solution three
times. The measurement of green fluorescence (oxidized
DCFH) using a microplate fluorometer (LB 941, Berthold
Technologies, Bad Wildbad, Germany) with fluorescence
intensity (excitation, 488 nm; emission, 530 nm). The total
protein concentration was determined using BCA protein
assay kits (Pierce, IL, USA). The cell-free wells containing
only ZnO NPs and DCFH were used to assess nonspecific
particle-induced fluorescence. Fluorescence was reported
with respect to unexposed control cells.
Assessment of mitochondrial membrane potential
Mitochondrial membrane potential (MMP) was deter-
mined with JC-1, a lipophilic membrane-permeable cat-
ionic probe, which is widely used for detecting MMP
[41]. After 6, 12, or 24 h exposure to 4, 8, or 12 μg/ml of
ZnO NPs, the cells were washed twice in PBS and were
incubated for 30 min at 37°C with JC-1, a lipophilic and
cationic dye that accumulates in the mitochondria in a
potential-dependent manner. The intensity of fluores-
cence was measured with a fluorescence multi-well plate
reader LB 941 (Berthold, Bad Wildbad, Germany) with
fluorescence intensity (green: excitation 488 nm, emis-
sion 530 nm; red: excitation 535 nm, emission 605 nm).
The results were presented as the ratio of intensity of
red and green fluorescence.
Nuclear staining with DAPI
Chromatin condensation was determined by 4, 6-
diamido-2-phenylindole dihydrochloride (DAPI) stai-
ning. Astrocytes were cultured in DMEM containing
10% fetal bovine serum on poly-L-lysine-coated dishes
or slides in 5% CO2, at 37°C then treated with 12 μg/ml
concentration of ZnO NPs for 6 h. The cells were col-
lected and sequentially washed three times in PBS and
then fixed for 15 min in 4% paraformaldehyde in PBS
for 30 min at room temperature. After staining with a
DAPI solution (10 μg/ml) for 10 min in the dark at
room temperature, the stained cells were washed twice
with PBS to remove the excess DAPI and the changes
of nucleus were examined with excitation of 330 to
380 nm and emission of 420 nm using a fluorescence
microscope (Olympus, Tokyo, Japan).
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Apoptosis was measured using the Annexin V-FITC apop-
tosis detection kit (Abcam, Mountain View, CA, USA) ac-
cording to the manufacturer's instructions. After treatment
with 4, 8, or 12 μg/ml of ZnO NPs for 6 h, the cells were
harvested with trypsin, washed twice with PBS (pH 7.4),
and then incubated with 200 μl of binding buffer contai-
ning Annexin V-FITC (40 μl/ml) and propidium iodide (PI;
1 μg/ml) for 15 min at room temperature in the dark. The
population of Annexin V-positive cells was analyzed by
flow cytometry (Epics XL, Beckman Coulter Inc, Pasadena,
CA, USA). The early apoptotic cells were located in the
lower right quadrant (Annexin V-FITC-positive/PI-negative
cells), and the late apoptotic cells were located in the upper
right quadrant (Annexin V-FITC-positive/PI-positive cells).
The percentages of apoptotic cells (Annexin V-positive
cells) were plotted.
Western blot analysis
The expression of Bcl-2, Bax, JNK, ERK1/2, PARP, p38
MAPK, phosphor-JNK, phosphor-ERK1/2, phosphor-
p38 MAPK, cleaved caspase-3, and β-actin in whole cell
lysates were analyzed by sodium dodecyl sulfate polya-
crylaminde gel electrophoresis (SDS-PAGE). The gels
were transferred to polyvinylidene difluoride (PVDF)
membrane by semi-dry electrophoretic transfer at 20 V
for 60 min using the semi-dry transfer system. The
PVDF membranes were blocked with 5% nonfat milk at
room temperature for 1 h, incubated with the primary
antibody (dilution 1:1,000) in Tris/buffered saline/
Tween20 (TBST) containing 5% bovine serum albumin
overnight in 4°C, and then incubated with the secondary
antibody (dilution 1:1,000) at room temperature for 1 h.
Immunoreactive bands were detected by an enhanced
chemiluminescence detection kit (Millipore Corporation,
Billerica, MA, USA) according to the manufacturer's in-
structions. β-actin was used as loading controls for theFigure 1 Characterization of ZnO nanoparticles. (A) Transmission electr
Magnification × 100,000. (B) Size distributions of ZnO NPs in H2O or DMEMtotal protein content and showed no differences between
groups.
Statistical analysis
Results were presented as mean ± standard deviation (SD)
of three representative experiments. Data were analyzed
using one-way analysis of variance (ANOVA) followed by
post hoc comparisons using the Dunnet's multiple com-
parison test or two-way ANOVA statistical analysis
followed by a post hoc test. A probability of value of p <
0.05 was considered as statistically significant.
Results
Characterization of ZnO NPs
Figure 1A shows the TEM images of ZnO NPs. The pic-
ture exhibits that the majority of ZnO NPs were rod-
shaped with smooth surfaces. The average TEM size of
ZnO NPs was about 45 nm. The surface area of ZnO NPs
determined by BET was 35 m2/g. The average hydro-
dynamic size of ZnO NPs in water and cell culture medium
determined by DLS was 2,181 and 747 nm, respectively.
The physicochemical characteristics of ZnO NPs are listed
in Table 1.
ZnO NP-induced cytotoxicity
The cytotoxicity of ZnO NPs in astrocytes was evaluated
with the MTT and LDH assays. The cell viability exam-
ined by MTT assay showed no statistically significant
impacts of ZnO NPs after 6, 12, or 24 h exposure of cells
to 4 μg/ml of ZnO NPs compared with the unexposed
control cells. However, a significant decrease of cell via-
bility was observed after 12 or 24 h exposure of cells to
8 or 12 μg/ml of ZnO NPs (Figure 2A).
Compared with the unexposed control cells, the level of
LDH released from the cells was significantly increased
after 12 or 24 h of exposure to 8 or 12 μg/ml of ZnO NPs
in dose- and time-dependent manner (Figure 2B). Theon microscope (TEM) image of ZnO NPs. Scale bars, 100 nm.
/F12 were analyzed by dynamic light scattering, respectively.
Table 1 Physicochemical characteristics of ZnO NPs
Parameters Values (mean ± SD)
Average TEM size (nm) 45 ± 27
Hydrodynamic size in distilled water (nm) 2181 ± 21
Hydrodynamic size in culture medium (nm) 747 ± 25
Surface area (m2/g) 35.34 ± 2.82
Description: zinc oxide, nanopowder.
Figure 2 Effect of ZnO NPs on cell viability in cultured primary
astrocytes. (A) MTT assay. (B) LDH release. Astrocytes were treated
with 4, 8, or 12 μg/ml of ZnO NPs for 6, 12, or 24 h, respectively. (C)
Inhibitory effect of N-acetylcysteine (NAC) on cell viability reduction.
Astrocytes were pretreated for 1 h with 0.05, 0.5, and 5 mM of NAC
before 6 h co-exposure with ZnO NPs (12 μg/ml). Data are presented
as mean ± SD of the three representative experiments. **p < 0.05,
***p < 0.001 vs. control. #p < 0.05 vs. ZnO NPs (12 μg/ml).
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cells induced by exposure to ZnO NPs is related to the cell
viability. As shown in Figure 2C, we also clearly observed
a significant inhibitory effect of NAC (5 mM) on cell via-
bility reduction (p < 0.05).
ZnO NPs caused cellular morphological modifications
To further determine whether ZnO NPs could result in
damage in astrocytes, we decided to observe the morpho-
logical changes at the ultrastructural level. As shown in
Figure 3A, the unexposed control cells remained smooth
and flat and also exhibited a cell surface evenly covered by
microvillar structures that are well extended with small
lamellapodia, indicating the fluidity and motility of normal
cells. However, ZnO NP-treated astrocytes exhibited the
conformation of numerous lamellapodia and filopodia that
were shown projecting from the cell membranes over the
substratum, which were probably caused by the aggrega-
tion of ZnO NPs in random clusters at the cell surface
(Figure 3A). As shown in Figure 3B, ZnO NP-exposed
cells displayed typical apoptotic features, including nuclear
shrinkage, chromatin condensation, and extensive cyto-
plasmic vacuolization after 6 h of exposure to 12 μg/ml of
ZnO NPs as compared to the unexposed control cells. In
addition, we noted that the engulfed ZnO NPs were visu-
alized in the damaged astrocytes.
ZnO NP-induced intracellular ROS generation
The level of ZnO NP-induced intracellular ROS gener-
ation was measured by DCF fluorescence intensity in
astrocytes. As shown in Figure 4A, a dose-dependent in-
crease of intracellular ROS generation was observed after
6 h of exposure to 8 and 12 μg/ml of ZnO NPs. Moreover,
we also found that after 12 h of exposure to 12 μg/ml of
ZnO NPs, the level of ROS was significantly higher than
that of the unexposed control cells (p < 0.001). However,
treatment with NAC significantly reduced ZnO NP-
induced ROS generation (Figure 4B).
ZnO NP-induced mitochondrial dysfunction
Healthy cells with functional mitochondria color stain
with red JC-aggregates while cells with impaired mito-
chondria stain with green JC-1 monomers. As shown in
Figure 5, ZnO NP-exposed cells exhibited a marked im-
pairment of mitochondria in a dose-dependent mannerevident by a shift in JC-1 florescence from red to green.
However, the MMP level was increased up to control
level for ZnO NPs in the presence of NAC (Figure 5).
Figure 3 SEM and TEM images of astrocytes exposed to ZnO NPs for 6 h. (A) SEM images. Scale bars, 10 and 1 μm. Magnification × 1,500
(left) and × 20,000 (right). (B) TEM image. N indicates nucleus. Scale bar, 5 μm. Magnification × 6,000.
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Figure 4 Effect of ZnO NPs on intracellular ROS generation in
cultured primary astrocytes. (A) ROS generation in astrocytes.
Cells were treated with 4, 8, or 12 μg/ml of ZnO NPs for 6, 12, or
24 h, respectively. (B) Inhibitory effect of NAC on ROS generation.
Astrocytes were pretreated for 1 h with 5 mM of NAC before 6 h of
co-exposure with ZnO NPs (12 μg/ml). Data are presented as the
mean± SD of three representative experiments. **p< 0.01, ***p< 0.001 vs.
control. #p < 0.05 vs. ZnO NPs (12 μg/ml).
Figure 5 Effect of ZnO NPs on mitochondrial transmembrane
potential in cultured primary astrocytes. The cells were treated
with 4, 8, or 12 μg/ml of ZnO NPs or 12 μg/ml of ZnO NPs plus
5 mM NAC for 6 h, respectively. Astrocytes were pretreated for 1 h
with 5 mM of NAC before 6 h of co-exposure with ZnO NPs (12 μg/ml).
Data are presented as the mean ± SD of three representative
experiments. *p < 0.05, **p < 0.01, ***p < 0.001 vs. control. #p < 0.05 vs.
ZnO NPs (12 μg/ml).
Wang et al. Nanoscale Research Letters 2014, 9:117 Page 7 of 12
http://www.nanoscalereslett.com/content/9/1/117ZnO NP-modulated intrinsic apoptosis
As shown in earlier, ZnO NPs markedly decreased MMP,
thus we further examined the levels of the key apoptotic
and signaling proteins involved in the mitochondrial path-
way of apoptosis in ZnO NP-exposed cells. As shown in
Figure 6A, ZnO NP-exposed astrocytes displayed chroma-
tin condensation as compared with unexposed control cells.
Moreover, as the exposure concentration of ZnO NPs was
increased from 4 to 12 μg/ml, the total number of apoptotic
cells increased from 5.79% to 72.78% (Figure 6B). Further-
more, the protein levels of Bax, cleaved PARP, and cleaved
caspase-3 were significantly up-regulated while the expres-
sion of Bcl-2 was significantly downregulated in ZnO NP-
exposed cells (Figure 6C). Correspondingly, Western
blotting data showed that pretreatment with NAC not
only significantly suppressed downregulation of Bcl-2
and up-regulation of Bax but also attenuated cleaved
PARP and cleaved caspase-3 expression induced by
ZnO NPs (Figure 6C).
Involvement of JNK/ERK/p38 MAPK signaling pathways in
the ZnO NP-induced apoptosis
To determine whether JNK/ERK/p38 MAPK signaling
pathways are involved in ZnO NP-induced apoptosis, we
firstly detected the phosphorylation of JNK, ERK, and p38
MAPK after exposure of astrocytes to 12 μg/ml of ZnO
NPs for 0, 6, 12, or 24 h. As shown in Figure 6A, ZnO
NPs rapidly and markedly increased JNK phosphorylation
at 6 and 12 h after exposure. The phosphorylation of ERK
was significantly increased from 6 to 24 h after exposure.
Moreover, there was a marked increase in p38 MAPK
phosphorylation from 6 to 24 h. In addition, when the
cells were treated with 4, 8, or 12 μg/ml of ZnO NPs for
6 h, phosphorylation of induction of JNK, ERK, and p38
MAPK seemed to be induced maximally after exposure to
ZnO NPs (12 μg/ml). These findings indicated that ZnO
NP exposure induces phosphorylation of JNK, ERK, and
p38 MAPK, respectively.
To confirm that the underlying mechanism of JNK/
ERK/p38 MAPK signaling pathways is involved in ZnO
NP-induced apoptosis, we next utilized JNK/ERK/p38
MAPK inhibitors after exposure of astrocytes to 12 μg/
ml of ZnO NPs for 6 h. As shown in Figure 6B, 10 μM
of JNK inhibitor (SP600125) significantly downregulated
the expression of cleaved PARP and cleaved caspase-3
after exposure to ZnO NPs (p < 0.001). However, pre-
treatment with either ERK 1/2 inhibitor (10 μM PD98059)
or p38 MAPK inhibitor (10 μM SB203580) did not affect
the expression of cleaved PARP and cleaved caspase-3.
In addition, we also found that LY294002 significantly
downregulated ZnO NP-induced cleaved PARP and cleaved
caspase-3 expression rather than SB203580 and PD98059
(Figure 6B). These results suggested that ZnO NP-induced
apoptosis is mediated by the JNK signaling pathway.
Figure 6 (See legend on next page.)
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Figure 6 Effect of ZnO NPs on apoptosis in cultured primary astrocytes. (A) Fluorescent images of chromosome condensation by DAPI
staining. Control cells (left), cells exposed to 12 μg/ml of ZnO NPs for 6 h (middle). Cells were pretreated for 1 h with 5 mM of NAC before 6 h
co-exposure with 12 μg/ml ZnO NPs (right). Scale bar, 50 μm. Magnification, ×400. (B) FACS results of the Annexin V-FITC and PI assays. Cells were
treated with 4, 8, or 12 μg/ml of ZnO NPs or 12 μg/ml of ZnO NPs plus 5 mM of NAC for 6 h, respectively. The astrocytes were pretreated for 1 h
with 5 mM of NAC before 6 h of co-exposure with ZnO NPs (12 μg/ml). The dot plots and the relative mean values have been obtained from a
single representative experiment of three representative experiments that gave very similar results. (C) Effect of ZnO NPs on the expression of
apoptosis-related proteins in cultured primary astrocytes. The cells were treated with 4, 8, or 12 μg/ml of ZnO NPs or 12 μg/ml of ZnO NPs plus
5 mM of NAC for 6 h or 12 μg/ml of ZnO NPs for 6, 12, or 24 h, respectively. The cells were collected to measure their protein expression levels
(cleaved PARP, cleaved caspase-3, Bcl-2, Bax, and β-actin) as described in the ‘Materials and methods’ section. Data are presented as the mean ± SD of
the three representative experiments. *p < 0.05, **p < 0.01, ***p < 0.001 vs. control. #p < 0.05, ##p < 0.01 vs. ZnO NPs (12 μg/ml).
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was involved in the JNK signaling pathway in astrocytes,
we further detected the phosphorylation of JNK after ex-
posure to ZnO NPs in the presence of NAC (5 mM) for
the indicated duration. As shown in Figure 7A, phosphor-
ylation of JNK was also markedly decreased after exposure
to ZnO NPs in the presence of NAC. Moreover, cleaved
PARP expression was significantly downregulated after
pretreatment with NAC. These findings indicated that the
JNK signaling pathway is involved in ROS-induced apop-
tosis in response to ZnO NPs.
Discussion
Nanoparticles are associated with neuroinflammation,
neurodegeneration, and increased risk for neurodegener-
ative diseases [42-44]. These associations are related to
the capability of nanoparticles to enter into the olfactory
bulb and to deposit in the central nervous system [6];
however, the exact mechanism involved in the cytotox-
icity is not fully described. Several studies have identified
the oxidative stress as common pathway for NP-induced
damage [14,23,45,46,47]. Recently, Guan et al. demon-
strated that ZnO NPs are capable of inducing oxidative
stress responses in human hepatocyte and embryonic
kidney cells [21]. In the present study, we showed that
exposure to ZnO NPs causes morphological alterations
and cytotoxicity. Moreover, ZnO NPs trigger an increase of
intracellular ROS in a dose-dependent manner, followed by
chromosome condensation, MMP depolarization, JNK/
ERK/p38 MAPK phosphorylation, and PARP cleavage in
cultured primary astrocytes. Furthermore, pretreatment
with JNK inhibitor (SP600125), but not ERK inhibitor
(U0126) or p38 MAPK inhibitor (SB203580), significantly
reduced ZnO NP-induced cleaved PARP and cleaved
caspase-3 expression, indicating that JNK signaling path-
way is involved in ZnO NP-induced apoptosis.
Accumulating evidences have indicated that nanoparti-
cles can induce neuron and glia cell apoptosis by targe-
ting the mitochondrial apoptosis pathway, which includes
activation loop phosphorylation, cytochrome c release
from the mitochondria, decrease in Bcl-2 protein ex-
pression, activation of PARP and caspase cascades, and
DNA fragmentation [10,12,44,48,49]. Here, our data alsoshowed that ZnO NP-induced oxidative stress followed by
significant reduction of the MMP and modifications of
Bax and Bcl-2 protein expression with an increase of
Bax levels and a corresponding decrease in Bcl-2 levels
(Figure 5A,B), leading to caspase-3 activation and PARP
cleavage. This observation is in agreement with an earlier
report demonstrating that ZnO NP exposure induced
apoptotic cell death via p53, survivin, Bax/Bcl-2, and cas-
pase pathways mediated by oxidative stress [50].
Oxidative stress is the result of an imbalance in the
pro-oxidant/antioxidant homeostasis. Various ROS,
such as superoxide, hydrogen peroxide, hydroxyl, and
other oxygen radicals, are involved in oxidative stress.
ROS function as signaling molecules in various path-
ways regulating both cell survival and cell death [19].
ROS is also reportedly associated with neurodegenera-
tive disorders, such as Alzheimer's disease, Parkinson's
disease, and Huntington's disease [44]. Generation of ROS
is considered to be up-stream event for the initiation of
NP-induced apoptotic signaling in vitro [51,52]. It has
been reported that the oxidative stress is a common
pathway for ZnO NP-induced oxidative damage [1,50,53].
Previous studies have identified mitochondria as the main
sources of ROS [54,55]. Others have shown that ROS
cause a decrease of the MMP and initiate mitochondria-
mediated apoptosis [56,57]. The cytotoxicity and oxidative
stress exerted by ZnO NPs and derived also from their
oxidative potential are probably associated with the nanole-
vel characteristic of ZnO NPs, disorder of electron trans-
port chain in mitochondria, and production of reduced
nicotinamide phosphate dinucleotide (NADPH) [45,58,59].
Here, our data showed that ZnO NP-induced ROS
triggered apoptosis and decreased the MMP because
ROS scavenger NAC markedly inhibited the processes
(Figures 4B and 5). Therefore, it is conceivable that ZnO
NP-induced ROS triggers a decrease of mitochondria
membrane potential that leads to apoptosis in astrocytes.
Sharma et al. described that the MAPK pathway regu-
lates apoptosis in response to ZnO NPs [45]. It is also well
known that JNK is an important regulator of cell apoptosis
and survival in response to oxidative stress [30,60]. In the
present study, we evaluated if the JNK, ERK1/2, and p38
MAPK pathways were involved in regulating ZnO NP-
Figure 7 Effect of ZnO NPs on ROS-dependent JNK/ERK/p38 MAPK activation in cultured primary astrocytes. (A) Cells were treated with
4, 8, or 12 μg/ml of ZnO NPs or 12 μg/ml of ZnO NPs plus 5 mM NAC for 6 h or 12 μg/ml of ZnO NPs for 6, 12, or 24 h, respectively. Cell lysates
were blotted for phospho-JNK, JNK, phospho-ERK1/2, ERK1/2, phospho-p38 MAPK, and p38 MAPK, respectively. The density of the phosphorylated-JNK/
ERK1/2/p38 MAPK was relative to the level of JNK/ERK1/2/p38 MAPK, respectively. (B) Cells were pretreated with the specific JNK inhibitor
(10 μM SP600125), ERK inhibitor (10 μM U0126) or p38 MAPK inhibitor (10 μM SB203580) for 1 h and then treated with 12 μg/ml ZnO NPs for
6 h, respectively. The cell lysates were blotted for total PARP, cleaved PARP, and cleaved caspase-3. The density of cleaved caspase-3 was relative
to the level of β-actin. Density of cleaved PARP was relative to the level of total PARP. Data are presented as the mean ± SD of three representative
experiments. **p < 0.01 and ***p < 0.001 vs. control. #p < 0.05 and ###p < 0.001 vs. ZnO NPs (12 μg/ml).
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http://www.nanoscalereslett.com/content/9/1/117induced apoptosis. We found that ZnO NPs induce a
time- and dose-dependent increase in the phosphorylation
of JNK, ERK, and p38 MAPK, which indicates that ZnO
NPs enhance the activities of these three stress-activated
protein kinases. However, treatment using the selective
MAPK inhibitors SP600125, U0126, and SB203580 signifi-
cantly resulted in the suppression of the PARP activation
and attenuated caspase-3 activity after exposed to ZnO
NPs, whereas SB203580 had no significant effects. Thus,
we propose that JNK pathway is involved in the apoptotic
process in primary astrocytes induced by ZnO NPs.
On the other hand, we also observed that NAC par-
tially suppressed the activation of JNK after ZnO NP ex-
posure, even when the oxidative stress is decreased. The
complementary evidence indicated that ROS generation
is associated with the activation of the JNK pathway, which
contributes to PARP and caspase-3 activation after expos-
ure to ZnO NPs. Wu et al. described that MAPK pathway
regulates apoptosis induced by oxidative stress in response
to TiO2 nanoparticles in neuron cells [49]. Recently, it has
been demonstrated that TiO2 nanoparticles activate the
MAPK signaling pathway and induced caspase-3-mediated
PARP cleavage [61].
Conclusions
In summary, the present study demonstrated that ZnO
NP-induced oxidative stress activates JNK signaling path-
way, compromising the integrity of cellular membranes
and leading to apoptosis of astrocytes. However, more in-
vestigations are needed to further explore the role of
apoptosis in ZnO NP-induced cytotoxicity and pathogen-
esis of neurodegenerative diseases associated with ZnO
NP exposure.
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